Guilhem, A., Fargeton, A., Simon, A., Duffau, P., Harle, J., Lavigne, C., . . . Rivière, S. (2017). Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients. PLoS One.
Citação norma ChicagoGuilhem, Alexandre, et al. "Intra-venous Bevacizumab in Hereditary Hemorrhagic Telangiectasia (HHT): A Retrospective Study of 46 Patients." PLoS One 2017.
MLA CitationGuilhem, Alexandre, et al. "Intra-venous Bevacizumab in Hereditary Hemorrhagic Telangiectasia (HHT): A Retrospective Study of 46 Patients." PLoS One 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.